NGLFINE · Concall Summary
NGL FINE CHEM LIMITED
The investor presentation for NGL Fine-Chem Limited for Q1FY27 reported sustained demand momentum from Q4FY26, with robust volumes across product segments and geographies. Management noted healthy operating margins, partly due to inventory gains from price increases, and indicated that margins may moderate as price realizations normalize. A forex gain of ₹2.5 crore in Q1FY27 contributed positively to profitability, reversing a loss from the previous quarter. The presentation highlighted that Phase II of their capital expenditure is on schedule for commissioning, with plans for commercial production in H2FY27. Management expressed confidence in medium-term earnings driven by demand and operating leverage. The presentation also included operational metrics, financial performance summaries, and strategic insights into the company's growth plans and market position.
Management expressed confidence in the company's growth and operational performance.
View source filing →Earlier concalls
- 2026-05-30 — During the Q4 and FY26 earnings conference call, management reported a strong performance with Q4 revenue from operation…
- 2026-05-22 — The investor presentation for NGL Fine-Chem Limited for Q4 and FY26 reported strong performance characterized by signifi…
- 2026-02-10 — In the investor presentation for Q3 and 9M FY26, NGL Fine-Chem Limited reported a strong performance across key financia…
See NGLFINE's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.
Sign up free